Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$87.80
À la fermeture: Oct 30, 4:11 PM EDT
$87.80
0.000.00%
Après les heures de négociation: 4:11 PM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
Glaukos Corp a un objectif de cours consensus de $120.25, basé sur les évaluations des 16 analystes. Le plus élevé est de $175 attribué par Mizuho le avril 16, 2025, et le plus bas est de $71 attribué par Stephens & Co. le mai 8, 2023. Les 3 dernières évaluations d'analystes ont été publiées par JP Morgan, Citigroup et Wells Fargo le octobre 30, 2025. Avec un objectif de cours moyen de $118.33 entre JP Morgan, Citigroup et Wells Fargo, il y a une variation implicite de 34.78% upside pour Glaukos Corp à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
JP Morgan
Citigroup
Wells Fargo
Needham
BTIG
1calculé à partir des notes des analystes
Notes d'analystes pour Glaukos
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/30/2025 | 36.67% | JP Morgan | $110 → $120 | Maintains | Overweight | |||
10/30/2025 | 28.7% | Citigroup | $110 → $113 | Maintains | Buy | |||
10/30/2025 | 38.95% | Wells Fargo | $120 → $122 | Maintains | Overweight | |||
10/30/2025 | 33.26% | Needham | $115 → $117 | Maintains | Buy | |||
10/30/2025 | 32.12% | BTIG | $104 → $116 | Maintains | Buy | |||
10/27/2025 | 36.67% | Wells Fargo | $92 → $120 | Upgrade | Equal-Weight → Overweight | |||
10/20/2025 | 18.45% | BTIG | $104 → $104 | Reiterates | Buy → Buy | |||
10/13/2025 | 18.45% | BTIG | $118 → $104 | Maintains | Buy | |||
10/07/2025 | 25.28% | Citigroup | $140 → $110 | Maintains | Buy | |||
10/01/2025 | 17.31% | Goldman Sachs | → $103 | Initiates | → Buy | |||
09/22/2025 | 36.67% | Truist Securities | $126 → $120 | Maintains | Buy | |||
09/10/2025 | 34.4% | BTIG | $118 → $118 | Reiterates | Buy → Buy | |||
07/31/2025 | 4.78% | Wells Fargo | $86 → $92 | Maintains | Equal-Weight | |||
07/31/2025 | 52.62% | UBS | $125 → $134 | Maintains | Buy | |||
05/06/2025 | -18% | Morgan Stanley | $110 → $72 | Maintains | Underweight | |||
05/02/2025 | 30.98% | Stephens & Co. | $140 → $115 | Maintains | Overweight | |||
05/01/2025 | 30.98% | Stifel | $140 → $115 | Maintains | Buy | |||
05/01/2025 | 53.76% | Truist Securities | $140 → $135 | Reiterates | Buy → Buy | |||
05/01/2025 | -2.05% | Wells Fargo | $160 → $86 | Downgrade | Overweight → Equal-Weight | |||
05/01/2025 | 30.98% | Needham | $176 → $115 | Maintains | Buy | |||
04/16/2025 | 99.32% | Mizuho | $200 → $175 | Maintains | Outperform | |||
04/15/2025 | 87.93% | Piper Sandler | $180 → $165 | Maintains | Overweight | |||
04/11/2025 | 59.45% | Truist Securities | $185 → $140 | Maintains | Buy | |||
02/21/2025 | 82.23% | Wells Fargo | $153 → $160 | Maintains | Overweight | |||
02/21/2025 | 100.46% | Needham | $149 → $176 | Maintains | Buy | |||
02/19/2025 | 127.79% | Mizuho | $140 → $200 | Upgrade | Neutral → Outperform | |||
01/27/2025 | 105.01% | Piper Sandler | $140 → $180 | Reiterates | Overweight → Overweight | |||
12/31/2024 | 99.32% | Stifel | $153 → $175 | Maintains | Buy | |||
12/18/2024 | 110.71% | Truist Securities | $152 → $185 | Maintains | Buy | |||
12/17/2024 | 59.45% | Mizuho | $115 → $140 | Maintains | Neutral | |||
12/11/2024 | 74.26% | Wells Fargo | $145 → $153 | Maintains | Overweight | |||
12/11/2024 | 84.51% | Citigroup | $132 → $162 | Upgrade | Neutral → Buy | |||
12/06/2024 | 107.29% | UBS | → $182 | Initiates | → Buy | |||
12/02/2024 | 74.26% | Stifel | $145 → $153 | Maintains | Buy | |||
12/02/2024 | 36.67% | Morgan Stanley | → $120 | Downgrade | Equal-Weight → Underweight | |||
11/26/2024 | 69.7% | BTIG | $140 → $149 | Maintains | Buy | |||
11/05/2024 | 65.15% | JP Morgan | $130 → $145 | Maintains | Overweight | |||
11/05/2024 | 65.15% | Wells Fargo | $135 → $145 | Maintains | Overweight | |||
10/14/2024 | 73.12% | Truist Securities | $145 → $152 | Maintains | Buy | |||
09/03/2024 | 65.15% | Stifel | $130 → $145 | Maintains | Buy | |||
08/28/2024 | 58.31% | BTIG | $131 → $139 | Maintains | Buy | |||
08/27/2024 | 69.7% | Needham | $137 → $149 | Maintains | Buy | |||
08/01/2024 | 59.45% | Piper Sandler | $110 → $140 | Maintains | Overweight | |||
08/01/2024 | 53.76% | Wells Fargo | $120 → $135 | Maintains | Overweight | |||
08/01/2024 | 65.15% | Truist Securities | $141 → $145 | Reiterates | Buy → Buy | |||
08/01/2024 | 56.04% | Needham | $131 → $137 | Maintains | Buy | |||
07/16/2024 | 60.59% | Truist Securities | $125 → $141 | Maintains | Buy | |||
07/15/2024 | 30.98% | Mizuho | $100 → $115 | Maintains | Neutral | |||
07/15/2024 | 49.2% | BTIG | $112 → $131 | Maintains | Buy | |||
07/15/2024 | 36.67% | Morgan Stanley | $100 → $120 | Maintains | Equal-Weight | |||
07/10/2024 | 50.34% | Citigroup | $130 → $132 | Downgrade | Buy → Neutral | |||
06/05/2024 | 48.06% | Stifel | $110 → $130 | Maintains | Buy | |||
06/03/2024 | 36.67% | Wells Fargo | $110 → $120 | Maintains | Overweight | |||
05/22/2024 | 48.06% | Citigroup | $120 → $130 | Maintains | Buy | |||
05/06/2024 | 42.37% | Jefferies | $84 → $125 | Upgrade | Hold → Buy | |||
05/02/2024 | 27.56% | BTIG | $107 → $112 | Maintains | Buy | |||
05/02/2024 | 25.28% | JP Morgan | $108 → $110 | Maintains | Overweight | |||
05/02/2024 | 25.28% | Wells Fargo | $103 → $110 | Maintains | Overweight | |||
05/02/2024 | 42.37% | Truist Securities | $120 → $125 | Reiterates | Buy → Buy | |||
05/02/2024 | 28.7% | Needham | $108 → $113 | Maintains | Buy | |||
04/11/2024 | 13.9% | Mizuho | $85 → $100 | Maintains | Neutral | |||
04/08/2024 | 25.28% | Truist Securities | $110 → $110 | Reiterates | Buy → Buy | |||
04/03/2024 | 25.28% | Stifel | → $110 | Reiterates | Buy → Buy | |||
03/25/2024 | 36.67% | Citigroup | $107 → $120 | Maintains | Buy | |||
03/22/2024 | 25.28% | Truist Securities | → $110 | Reiterates | Buy → Buy | |||
02/22/2024 | 17.31% | Wells Fargo | $83 → $103 | Maintains | Overweight | |||
02/22/2024 | 23.01% | Needham | $105 → $108 | Maintains | Buy | |||
02/16/2024 | 19.59% | Needham | $105 → $105 | Reiterates | Buy → Buy | |||
12/29/2023 | 13.9% | Truist Securities | $100 → $100 | Reiterates | Buy → Buy | |||
12/22/2023 | 19.59% | Piper Sandler | $90 → $105 | Maintains | Overweight | |||
12/22/2023 | 13.9% | Truist Securities | $88 → $100 | Maintains | Buy | |||
12/21/2023 | 3.64% | JP Morgan | $66 → $91 | Upgrade | Neutral → Overweight | |||
12/04/2023 | -25.97% | Morgan Stanley | → $65 | Initiates | → Equal-Weight | |||
11/28/2023 | 0.23% | Truist Securities | → $88 | Initiates | → Buy | |||
11/08/2023 | -5.47% | Wells Fargo | $75 → $83 | Upgrade | Equal-Weight → Overweight | |||
11/02/2023 | -24.83% | JP Morgan | $71 → $66 | Maintains | Neutral | |||
11/02/2023 | -5.47% | Needham | $89 → $83 | Maintains | Buy | |||
09/26/2023 | 2.51% | Stifel | → $90 | Reiterates | Buy → Buy | |||
08/03/2023 | 2.51% | Piper Sandler | $85 → $90 | Maintains | Overweight | |||
08/03/2023 | -3.19% | Mizuho | $80 → $85 | Maintains | Neutral | |||
08/03/2023 | 1.37% | Needham | → $89 | Reiterates | Buy → Buy | |||
07/31/2023 | -3.19% | Piper Sandler | $80 → $85 | Maintains | Overweight | |||
07/19/2023 | 1.37% | Needham | $67 → $89 | Maintains | Buy | |||
07/14/2023 | -14.58% | Wells Fargo | $63 → $75 | Maintains | Equal-Weight | |||
07/11/2023 | -3.19% | Citigroup | $59 → $85 | Maintains | Buy | |||
06/26/2023 | -12.3% | Stifel | $65 → $77 | Maintains | Buy | |||
06/07/2023 | -8.88% | Piper Sandler | $55 → $80 | Upgrade | Neutral → Overweight | |||
06/05/2023 | -23.69% | BTIG | $58 → $67 | Maintains | Buy | |||
06/05/2023 | -28.25% | Wells Fargo | $44 → $63 | Maintains | Equal-Weight | |||
05/08/2023 | -19.13% | Stephens & Co. | → $71 | Reiterates | → Overweight | |||
05/04/2023 | -21.41% | Stephens & Co. | → $69 | Reiterates | → Overweight | |||
05/04/2023 | -33.94% | Needham | $57 → $58 | Maintains | Buy | |||
04/18/2023 | -40.77% | Mizuho | $48 → $52 | Maintains | Neutral | |||
02/23/2023 | -45.33% | JP Morgan | $42 → $48 | Maintains | Neutral | |||
02/23/2023 | -32.8% | Citigroup | $57 → $59 | Maintains | Buy | |||
02/23/2023 | -35.08% | Needham | $58 → $57 | Maintains | Buy | |||
12/28/2022 | -22.55% | Stephens & Co. | $69 → $68 | Maintains | Overweight | |||
12/22/2022 | -45.33% | Mizuho | → $48 | Initiates | → Neutral | |||
12/19/2022 | -52.16% | JP Morgan | $48 → $42 | Upgrade | Underweight → Neutral | |||
12/12/2022 | -49.89% | Wells Fargo | $56 → $44 | Maintains | Equal-Weight |
FAQ
Quel est le cours indicatif de l'action Glaukos (GKOS) ?
Le dernier objectif de prix pour Glaukos (NYSE:GKOS) a été rapporté par JP Morgan le octobre 30, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $120.00 s'attendant à ce que GKOS se rise dans les 12 prochains mois (un possible changement de 36.67% upside). 38 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour Glaukos (GKOS) ?
La dernière note d'analyste pour Glaukos (NYSE:GKOS) a été fournie par JP Morgan, et Glaukos maintenu leur note overweight.
Quand a eu lieu la dernière mise à niveau pour Glaukos (GKOS) ?
La dernière amélioration pour Glaukos Corp a eu lieu le octobre 27, 2025 lorsque Wells Fargo a augmenté leur objectif de prix à $120. Wells Fargo avait précédemment an equal-weight pour Glaukos Corp.
Quand a eu lieu la dernière dégradation pour Glaukos (GKOS) ?
La dernière réduction pour Glaukos Corp a eu lieu le mai 1, 2025 lorsque Wells Fargo a changé leur objectif de prix de $160 à $86 pour Glaukos Corp.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour Glaukos (GKOS) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Glaukos, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Glaukos a été déposée le octobre 30, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 30, 2026.
La note d'analyste pour Glaukos (GKOS) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de Glaukos (GKOS) était un maintenu avec un objectif de prix de $110.00 à $120.00. Le prix actuel de Glaukos (GKOS) est de $87.80, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.